🔎 Trials Near Me

Home › Diffuse Intrinsic Pontine Glioma › Ohio › Cincinnati

Diffuse Intrinsic Pontine Glioma clinical trials in Cincinnati, OH

10 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

RecruitingPhase 2
  • Cincinnati Children's Hospital, Cincinnati
12 Months – 39 Years · All sexes · Updated Sep 21, 2026 · NCT06838676

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

RecruitingPhase 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944

Targeted Pediatric High-Grade Glioma Therapy

RecruitingObservational study
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RecruitingPhase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

RecruitingPhase 1/2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ages 4 to 39 · All sexes · Updated Jul 20, 2026 · NCT05278208

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RecruitingEarly phase 1Healthy volunteers welcome
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ages 1 to 21 · All sexes · Updated Jun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RecruitingPhase 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
12 Months – 39 Years · All sexes · Updated May 29, 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

RecruitingEarly phase 1
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Up to age 21 · All sexes · Updated Mar 18, 2026 · NCT04655404

International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository

RecruitingObservational study
  • Cincinnati Children's Hospital Medical Center, Cincinnati
All ages · All sexes · Updated Oct 20, 2025 · NCT03101813

Diffuse Intrinsic Pontine Glioma trials in other cities

Other studies in Cincinnati

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.